Skip to main content

Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversion.

Publication ,  Journal Article
Giroux, NS; Ding, S; McClain, MT; Burke, TW; Petzold, E; Chung, HA; Rivera, GO; Wang, E; Xi, R; Bose, S; Rotstein, T; Nicholson, BP; Chen, T ...
Published in: Sci Rep
July 9, 2022

SARS-CoV-2 infection triggers profound and variable immune responses in human hosts. Chromatin remodeling has been observed in individuals severely ill or convalescing with COVID-19, but chromatin remodeling early in disease prior to anti-spike protein IgG seroconversion has not been defined. We performed the Assay for Transposase-Accessible Chromatin using sequencing (ATAC-seq) and RNA-seq on peripheral blood mononuclear cells (PBMCs) from outpatients with mild or moderate symptom severity at different stages of clinical illness. Early in the disease course prior to IgG seroconversion, modifications in chromatin accessibility associated with mild or moderate symptoms were already robust and included severity-associated changes in accessibility of genes in interleukin signaling, regulation of cell differentiation and cell morphology. Furthermore, single-cell analyses revealed evolution of the chromatin accessibility landscape and transcription factor motif accessibility for individual PBMC cell types over time. The most extensive remodeling occurred in CD14+ monocytes, where sub-populations with distinct chromatin accessibility profiles were observed prior to seroconversion. Mild symptom severity was marked by upregulation of classical antiviral pathways, including those regulating IRF1 and IRF7, whereas in moderate disease, these classical antiviral signals diminished, suggesting dysregulated and less effective responses. Together, these observations offer novel insight into the epigenome of early mild SARS-CoV-2 infection and suggest that detection of chromatin remodeling in early disease may offer promise for a new class of diagnostic tools for COVID-19.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Sci Rep

DOI

EISSN

2045-2322

Publication Date

July 9, 2022

Volume

12

Issue

1

Start / End Page

11714

Location

England

Related Subject Headings

  • Severity of Illness Index
  • Seroconversion
  • SARS-CoV-2
  • Leukocytes, Mononuclear
  • Immunoglobulin G
  • Humans
  • Chromatin
  • COVID-19
  • Antiviral Agents
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Giroux, N. S., Ding, S., McClain, M. T., Burke, T. W., Petzold, E., Chung, H. A., … Woods, C. W. (2022). Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversion. Sci Rep, 12(1), 11714. https://doi.org/10.1038/s41598-022-15668-8
Giroux, Nicholas S., Shengli Ding, Micah T. McClain, Thomas W. Burke, Elizabeth Petzold, Hong A. Chung, Grecia O. Rivera, et al. “Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversion.Sci Rep 12, no. 1 (July 9, 2022): 11714. https://doi.org/10.1038/s41598-022-15668-8.
Giroux NS, Ding S, McClain MT, Burke TW, Petzold E, Chung HA, et al. Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversion. Sci Rep. 2022 Jul 9;12(1):11714.
Giroux, Nicholas S., et al. “Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversion.Sci Rep, vol. 12, no. 1, July 2022, p. 11714. Pubmed, doi:10.1038/s41598-022-15668-8.
Giroux NS, Ding S, McClain MT, Burke TW, Petzold E, Chung HA, Rivera GO, Wang E, Xi R, Bose S, Rotstein T, Nicholson BP, Chen T, Henao R, Sempowski GD, Denny TN, De Ussel MI, Satterwhite LL, Ko ER, Ginsburg GS, Kraft BD, Tsalik EL, Shen X, Woods CW. Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversion. Sci Rep. 2022 Jul 9;12(1):11714.

Published In

Sci Rep

DOI

EISSN

2045-2322

Publication Date

July 9, 2022

Volume

12

Issue

1

Start / End Page

11714

Location

England

Related Subject Headings

  • Severity of Illness Index
  • Seroconversion
  • SARS-CoV-2
  • Leukocytes, Mononuclear
  • Immunoglobulin G
  • Humans
  • Chromatin
  • COVID-19
  • Antiviral Agents